Stockreport

Insmed TPIP Data At PVRI 2026 Tests Pulmonary Arterial Hypertension Ambitions [Yahoo! Finance]

Insmed, Inc.  (INSM) 
Last insmed, inc. earnings: 4/30 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.insmed.com
PDF Insmed (NasdaqGS:INSM) plans to present new clinical and preclinical research on treprostinil palmitil inhalation powder (TPIP) at PVRI 2026. The company will share P [Read more]